Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT04630860
Brief Summary:
This study is to evaluate the pharmacokinetics and safety of LY03003 in patients with advanced-stage PD.
Study:
NCT04630860
Study Brief:
Protocol Section:
NCT04630860